These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discovery of 1,2,4-oxadiazole-Containing hydroxamic acid derivatives as histone deacetylase inhibitors potential application in cancer therapy. Yang Z, Shen M, Tang M, Zhang W, Cui X, Zhang Z, Pei H, Li Y, Hu M, Bai P, Chen L. Eur J Med Chem; 2019 Sep 15; 178():116-130. PubMed ID: 31177073 [Abstract] [Full Text] [Related]
3. Design, synthesis and biological evaluation of novel indole derivatives as potential HDAC/BRD4 dual inhibitors and anti-leukemia agents. Cheng G, Wang Z, Yang J, Bao Y, Xu Q, Zhao L, Liu D. Bioorg Chem; 2019 Mar 15; 84():410-417. PubMed ID: 30554080 [Abstract] [Full Text] [Related]
4. Utilization of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidinone as a cap moiety in design of novel histone deacetylase inhibitors. Mohamed MFA, Youssif BGM, Shaykoon MSA, Abdelrahman MH, Elsadek BEM, Aboraia AS, Abuo-Rahma GEA. Bioorg Chem; 2019 Oct 15; 91():103127. PubMed ID: 31374527 [Abstract] [Full Text] [Related]
6. Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer. Ren Y, Li S, Zhu R, Wan C, Song D, Zhu J, Cai G, Long S, Kong L, Yu W. J Med Chem; 2021 Jun 10; 64(11):7468-7482. PubMed ID: 34043359 [Abstract] [Full Text] [Related]
7. Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors. Chen J, Li D, Li W, Yin J, Zhang Y, Yuan Z, Gao C, Liu F, Jiang Y. Bioorg Med Chem; 2018 Aug 07; 26(14):3958-3966. PubMed ID: 29954683 [Abstract] [Full Text] [Related]
9. Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors. Zhang Z, Hou S, Chen H, Ran T, Jiang F, Bian Y, Zhang D, Zhi Y, Wang L, Zhang L, Li H, Zhang Y, Tang W, Lu T, Chen Y. Bioorg Med Chem Lett; 2016 Jun 15; 26(12):2931-2935. PubMed ID: 27142751 [Abstract] [Full Text] [Related]
10. Design, synthesis and biological evaluation of 4-anilinothieno[2,3-d]pyrimidine-based hydroxamic acid derivatives as novel histone deacetylase inhibitors. Yang W, Li L, Ji X, Wu X, Su M, Sheng L, Zang Y, Li J, Liu H. Bioorg Med Chem; 2014 Nov 01; 22(21):6146-55. PubMed ID: 25261927 [Abstract] [Full Text] [Related]
19. New aryldithiolethione derivatives as potent histone deacetylase inhibitors. Tazzari V, Cappelletti G, Casagrande M, Perrino E, Renzi L, Del Soldato P, Sparatore A. Bioorg Med Chem; 2010 Jun 15; 18(12):4187-94. PubMed ID: 20576572 [Abstract] [Full Text] [Related]
20. Hydroxamic Acid Derivatives of β-Carboline/Hydroxycinnamic Acid Hybrids Inducing Apoptosis and Autophagy through the PI3K/Akt/mTOR Pathways. Ling Y, Li Y, Zhu R, Qian J, Liu J, Gao W, Meng C, Miao J, Xiong B, Qiu X, Ling C, Dai H, Zhang Y. J Nat Prod; 2019 Jun 28; 82(6):1442-1450. PubMed ID: 31120744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]